Association between mRNA vaccination and COVID-19 hospitalization and disease severity
Importance A comprehensive understanding of the benefits of COVID-19 vaccination requires
consideration of disease attenuation, determined as whether people who develop COVID-…
consideration of disease attenuation, determined as whether people who develop COVID-…
Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective …
…, CG Grijalva, TW Rice, WB Stubblefield, A Baughman… - bmj, 2022 - bmj.com
Objectives To characterize the clinical severity of covid-19 associated with the alpha, delta,
and omicron SARS-CoV-2 variants among adults admitted to hospital and to compare the …
and omicron SARS-CoV-2 variants among adults admitted to hospital and to compare the …
[HTML][HTML] Effectiveness of SARS-CoV-2 mRNA vaccines for preventing Covid-19 hospitalizations in the United States
Background: As SARS-CoV-2 vaccination coverage increases in the United States (US), there
is a need to understand the real-world effectiveness against severe Covid-19 and among …
is a need to understand the real-world effectiveness against severe Covid-19 and among …
Effectiveness of severe acute respiratory syndrome coronavirus 2 messenger RNA vaccines for preventing coronavirus disease 2019 hospitalizations in the United …
…, ID Jones, WB Stubblefield, A Baughman… - Clinical infectious …, 2022 - academic.oup.com
Background As severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
vaccination coverage increases in the United States, there is a need to understand the real-world …
vaccination coverage increases in the United States, there is a need to understand the real-world …
Seroprevalence of SARS-CoV-2 among frontline healthcare personnel during the first month of caring for patients with COVID-19—Nashville, Tennessee
…, MJ Ward, CJ Lindsell, A Baughman… - Clinical infectious …, 2021 - academic.oup.com
Among 249 healthcare personnel who worked in hospital units with COVID-19 patients for 1
month, 19 (7.6%) tested positive for SARS-CoV-2 antibodies. Only 11 (57.9%) of the 19 …
month, 19 (7.6%) tested positive for SARS-CoV-2 antibodies. Only 11 (57.9%) of the 19 …
[HTML][HTML] Clinical severity and mRNA vaccine effectiveness for omicron, delta, and alpha SARS-CoV-2 variants in the United States: a prospective observational study
…, CG Grijalva, TW Rice, WB Stubblefield, A Baughman… - MedRxiv, 2022 - ncbi.nlm.nih.gov
Objectives To characterize the clinical severity of COVID-19 caused by Omicron, Delta, and
Alpha SARS-CoV-2 variants among hospitalized adults and to compare the effectiveness of …
Alpha SARS-CoV-2 variants among hospitalized adults and to compare the effectiveness of …
Changing severity and epidemiology of adults hospitalized with coronavirus disease 2019 (COVID-19) in the United States after introduction of COVID-19 vaccines …
…, KW Gibbs, JH Kwon, A Baughman… - Clinical infectious …, 2023 - academic.oup.com
Introduction Understanding the changing epidemiology of adults hospitalized with coronavirus
disease 2019 (COVID-19) informs research priorities and public health policies. Methods …
disease 2019 (COVID-19) informs research priorities and public health policies. Methods …
mRNA vaccine effectiveness against coronavirus disease 2019 hospitalization among solid organ transplant recipients
…, CJ Lindsell, KW Hart, A Baughman… - The Journal of …, 2022 - academic.oup.com
Background The study objective was to evaluate 2- and 3-dose coronavirus disease 2019 (COVID-19)
mRNA vaccine effectiveness (VE) in preventing COVID-19 hospitalization among …
mRNA vaccine effectiveness (VE) in preventing COVID-19 hospitalization among …
Ascertainment of vaccination status by self‐report versus source documentation: Impact on measuring COVID‐19 vaccine effectiveness
…, JD Chappell, AS Lauring, A Baughman… - Influenza and other …, 2022 - Wiley Online Library
Background During the COVID‐19 pandemic, self‐reported COVID‐19 vaccination might
facilitate rapid evaluations of vaccine effectiveness (VE) when source documentation (eg, …
facilitate rapid evaluations of vaccine effectiveness (VE) when source documentation (eg, …
[HTML][HTML] SARS-CoV-2 shedding and evolution in immunocompromised hosts during the Omicron period: a multicenter prospective analysis
…, N Halasa, HK Talbot, CG Grijalva, A Baughman… - medRxiv, 2023 - ncbi.nlm.nih.gov
Background: Prolonged SARS-CoV-2 infections in immunocompromised hosts may predict
or source the emergence of highly mutated variants. The types of immunosuppression …
or source the emergence of highly mutated variants. The types of immunosuppression …
